e-learning
resources
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension
Marylise Ginoux, Ségolène Turquier, Nader Chebib, Jean-Charles Glerant, Julie Traclet, François Philit, Agathe Sénéchal, Jean-François Mornex, Vincent Cottin
Source:
ERJ Open Res, 4 (4) 00100-2018; 10.1183/23120541.00100-2018
Journal Issue:
October
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marylise Ginoux, Ségolène Turquier, Nader Chebib, Jean-Charles Glerant, Julie Traclet, François Philit, Agathe Sénéchal, Jean-François Mornex, Vincent Cottin. Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension. ERJ Open Res, 4 (4) 00100-2018; 10.1183/23120541.00100-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Patient with ankylosing spondylitis and pulmonary hypertension
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017
Year: 2018
Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a psychiatric disorder
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Prevalence of pulmonary hypertension in patients undergo hemodialysis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Impact of obesity on pulmonary rehabilitation in COPD patients
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011
Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006
Impact of co-morbidities on the rehabilitation outcome in COPD patients
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
The prevalence of pulmonary hypertension and the related factors in hemodialysis patients
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
The prevalence and affecting factors of pulmonary hypertension in hemodialysis patients
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018
Year: 2018
Prevalence of comorbidities in patients with COPD in south-Spain
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Prognostic predictors in younger and older incident idiopathic pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Prevalence of pulmonary hypertension in patients after splenectomy
Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease
Year: 2008
Predictors of health status in chronic obstructive pulmonary disease patients over three years
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept